STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALPXU
  4. [8-K] Alpex Acquisition Corp Reports Material Event

Alpex Acquisition (NASDAQ: ALPXU) completes $115M SPAC IPO and funds trust

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Alpex Acquisition Corporation completed its initial public offering of 11,500,000 units at $10.00 per unit, including the full over-allotment, raising gross proceeds of $115,000,000.

Each unit includes one Class A ordinary share, one redeemable warrant exercisable at $11.50 per share, and one right to receive one-fourth of a Class A ordinary share upon a future business combination. Substantially concurrently, the sponsor purchased 187,500 private units at $10.00 each for an additional $1,875,000 in gross proceeds.

A total of $115,000,000 of IPO and private placement proceeds was placed in a trust account and will remain there until a business combination or specified shareholder redemption events, with a 12‑month deadline from IPO consummation. The company also issued 230,000 Class A shares to the underwriters’ representative as compensation and appointed three independent directors, one designated as an audit committee financial expert, while adopting amended and restated governing documents.

Positive

  • Completed IPO and funded trust: Sold 11,500,000 public units at $10.00 plus 187,500 private units, with $115,000,000 placed into a trust account to support a future business combination.

Negative

  • None.

Insights

Alpex raises $116.9M gross and fully funds its SPAC trust.

Alpex Acquisition Corporation has launched as a special-purpose acquisition company by selling 11,500,000 public units at $10.00 each and 187,500 private units to its sponsor. Gross proceeds total $116,875,000, with the public component driving the SPAC’s investable pool.

The filing states that $115,000,000 was deposited into a trust account at $10.00 per public unit. These funds are restricted until a business combination or specified redemption events, giving public shareholders cash-backed protection while creating a defined 12‑month window to complete a deal.

Governance is set up with three independent directors and an audit committee financial expert, and the underwriters received 230,000 Class A shares plus lock-up and voting commitments. The economics, trust size, and timeline will frame any future merger negotiations and shareholder redemption decisions.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Public units sold 11,500,000 units at $10.00 Initial public offering including full over-allotment
IPO gross proceeds $115,000,000 Gross proceeds from sale of public units
Private placement units 187,500 units at $10.00 Sponsor private placement concurrent with IPO
Private placement proceeds $1,875,000 Gross proceeds from sponsor private units
Funds deposited in trust $115,000,000 Net IPO and private placement proceeds placed in trust
Underwriter share compensation 230,000 Class A shares Representative shares issued at IPO closing
Director share transfer 20,000 Class A shares each at ~$0.01 Sponsor transfers to three directors via Securities Transfer Agreement
Business combination deadline 12 months Period from IPO consummation to complete initial business combination
initial public offering financial
"relating to the initial public offering (the “IPO”) of Alpex Acquisition Corporation"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
over-allotments financial
"includes the full exercise of the underwriters’ option to purchase an additional 1,500,000 units to cover over-allotments"
An over-allotment is a temporary extra batch of shares that the underwriters of a stock offering are allowed to sell beyond the original amount, with the right to buy those shares back later. Think of it as spare tickets sold to meet demand and then reclaimed if needed to keep the market orderly; it helps stabilize the stock price after an offering and can affect short-term supply and potential dilution, which matters to investors tracking price and ownership stakes.
redeemable warrant financial
"one redeemable warrant (the “Warrant”), each Warrant entitling the holder thereof to purchase one Class A Ordinary Share"
A redeemable warrant is a financial tool that gives its holder the right to buy shares of a company at a fixed price within a certain period. If the holder chooses to do so, the company can buy back or cancel the warrant before it expires, often to encourage investment or manage share issuance. For investors, it provides an option to potentially buy shares at a favorable price while offering some flexibility for the issuing company.
trust account financial
"A total of $115,000,000, from the proceeds of the IPO and the sale of the Private Units ... were placed in the Company’s trust account."
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
audit committee financial expert regulatory
"has determined that Xin Yue Jasmine Geffner qualifies as an “audit committee financial expert”"
A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What did Alpex Acquisition Corporation (ALPXU) raise in its IPO?
Alpex raised $115,000,000 in gross proceeds by selling 11,500,000 units at $10.00 each. Each unit includes a Class A share, a redeemable warrant, and a right to receive one-fourth of a Class A share after a business combination.

How much money from the ALPXU IPO was placed in the trust account?
Alpex placed $115,000,000 into a trust account from the IPO and private placement proceeds. These funds remain restricted until a business combination or specified shareholder redemption events, with a 12‑month deadline from the IPO closing to complete a transaction.

What are the key terms of the ALPXU units and warrants?
Each Alpex unit includes one Class A ordinary share, one redeemable warrant, and one right. Each warrant allows purchase of one Class A share at an exercise price of $11.50 per share, while each right converts into one-fourth of a Class A share upon a business combination.

What private placement did the ALPXU sponsor complete?
Alpex’s sponsor bought 187,500 private units at $10.00 per unit, generating $1,875,000 in gross proceeds. These private units mirror the public units but carry transfer restrictions and other limited differences described in the registration statement and final prospectus.

Who joined the Alpex Acquisition Corporation board after the IPO?
Effective with the Nasdaq listing, “Joy” Yi Hua, Xin Yue Jasmine Geffner, and Yuanmei Ma became directors. The board determined all three are independent, and designated Xin Yue Jasmine Geffner as an audit committee financial expert under applicable SEC and Nasdaq standards.

What is the SPAC deadline for Alpex (ALPXU) to complete a business combination?
Alpex must complete its initial business combination within 12 months from the IPO’s consummation. Failing that, public shares are subject to redemption, as outlined in the amended and restated memorandum and articles of association adopted on June 24, 2026.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 29, 2026 (June 24, 2026)

 

Alpex Acquisition Corporation
(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-43369   N/A
(State or other jurisdiction   (Commission File Number)   (IRS Employer
of incorporation)       Identification Number)

 

300 Delaware Ave. Suite 210 #494
Wilmington, DE 19801

(Address of principal executive offices)

 

(302) 251-6637

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act.

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Units, consisting of one Class A ordinary share, $0.0001 par value, one redeemable Warrant to acquire one Class A ordinary share, and one Right to acquire one-fourth of one Class A ordinary share   ALPXU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   ALPX   The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   ALPXW   The Nasdaq Stock Market LLC
Rights, each whole right to acquire one-fourth of one Class A ordinary share   ALPXR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On June 24, 2026, the Registration Statement on Form S-1 (File No. 333-294978) (the “Registration Statement”) relating to the initial public offering (the “IPO”) of Alpex Acquisition Corporation, a Cayman Islands exempted company (the “Company”), was declared effective by the U.S. Securities and Exchange Commission. On June 26, 2026, the Company consummated the IPO of 11,500,000 units (the “Units”), which includes the full exercise of the underwriters’ option to purchase an additional 1,500,000 units to cover over-allotments. Each Unit consists of one Class A ordinary share, $0.0001 par value per share (each, a “Class A Ordinary Share”), one redeemable warrant (the “Warrant”), each Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, and one right (each, a “Right”), each Right entitling the holder thereof to exchange for one-fourth of one Class A Ordinary Share upon the completion of the Company’s initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $115,000,000.

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 187,500 units (the “Private Units”) to the Company’s Sponsor, Hugreat Ltd, a British Virgin Islands company (the “Sponsor”). Each Private Unit consists of one Class A Ordinary Share, one Warrant (the “Private Warrants”), and one Right (the “Private Rights”). The Private Units are identical to the Units sold in the IPO, subject to limited exceptions as further described in the Registration Statement. The Private Units were sold at $10.00 per Unit, generating gross proceeds of $1,875,000.

 

The Company also issued to D. Boral Capital LLC, the representative of the underwriters of the IPO (the “Representative”), 230,000 Class A Ordinary Shares as part of the underwriting compensation (the “Representative Shares”) on the closing of the IPO. The Representative Shares are identical to the Class A Ordinary Shares included in the Units, except that the Representative has agreed not to transfer, assign, sell, pledge, or hypothecate any such Representative Shares, or subject such Representative Shares to hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the securities by any person until 180 days immediately following the commencement of sales of the IPO pursuant to FINRA Rule 5110(e)(1), subject to exceptions pursuant to FINRA Rule 5110(e)(2), other than (i) the Representative or an underwriter or selected dealer in connection with the IPO, or (ii) a bona fide officer or partner of the Representative or of any such underwriter or selected dealer. In addition, the Representative has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company’s initial business combination, (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete its initial business combination within the period as provided in the Company’s Amended and Restated Memorandum and Articles of Association, and (iii) to vote the Representative Shares in favor of any proposed business combination.

 

In connection with the IPO, the Company entered into the following agreements, the forms of which were previously filed as exhibits to the Registration Statement:

 

  ● the Underwriting Agreement, dated June 24, 2026 (the “Underwriting Agreement”), between the Company and the Representative;

 

  ●

the Warrant Agreement, dated June 24, 2026, between the Company and VStock Transfer, LLC (“VStock”), as warrant agent (the “Warrant Agreement”);

 

  ● the Rights Agreement, dated June 24, 2026, between the Company and VStock, as rights agent (the “Rights Agreement”);

 

  ● the Securities Transfer Agreement, dated June 24, 2026, among the Company and certain directors of the Company (the “Securities Transfer Agreement”);

 

  ● the Private Unit Subscription Agreement, dated June 24, 2026, between the Company and the Sponsor;

 

  ● the Investment Management Trust Agreement, dated June 24, 2026, between the Company and Equiniti Trust Company, LLC (“Equiniti”), as trustee;

 

  ● the Registration Rights Agreement, dated June 24, 2026, among the Company, the Sponsor, and certain officers and directors of the Company;

 

  ● the Letter Agreement, dated June 24, 2026, among the Company, the Sponsor, and certain officers and directors of the Company; and

 

  ● the Indemnity Agreement, dated June 24, 2026, between the Company and each of the officers and directors of the Company.

 

The Underwriting Agreement is filed as Exhibit 1.1, the Warrant Agreement is filed as Exhibit 4.1 and the Rights Agreement is filed as Exhibit 4.2, and the other agreements set forth above are filed as Exhibits 10.1 to 10.10, respectively, to this report, and each of such exhibits is incorporated by reference herein.

 

1

 

Item 3.02 Unregistered Sales of Equity Securities

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 187,500 Private Units to the Sponsor for an aggregate purchase price of $1,875,000. The Private Units are identical to the Units issued in the IPO, except that the holders have agreed not to transfer, assign or sell any of the Private Units and the underlying securities (except for certain permitted transferees) until the completion of the Company’s initial business combination. The issuance of the Private Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective on June 25, 2026, in connection with the listing of the Company’s Units on the Nasdaq Global Market, “Joy” Yi Hua, Xin Yue Jasmine Geffner, and Yuanmei Ma became directors of the Company.

 

The board of directors of the Company has determined that each of “Joy” Yi Hua, Xin Yue Jasmine Geffner, and Yuanmei Ma are independent directors under the requirements of the Nasdaq listing standards and under the Securities Exchange Act of 1934, as amended (“Exchange Act”), and has determined that Xin Yue Jasmine Geffner qualifies as an “audit committee financial expert” as that term is defined in Item 407(d)(5) of Regulation S-K under the Exchange Act. “Joy” Yi Hua, Xin Yue Jasmine Geffner, and Yuanmei Ma will serve as members of the audit committee, with Xin Yue Jasmine Geffner serving as chair of the audit committee.

 

Substantially concurrently with the effectiveness of the registration statement and closing of the IPO (including the full exercise of over-allotment option), the Sponsor transferred each of “Joy” Yi Hua, Xin Yue Jasmine Geffner, and Yuanmei Ma 20,000 Class A Ordinary Shares at the same price originally paid by the Sponsor for such shares, approximately $0.01 per share, pursuant to the Securities Transfer Agreement. The Company will reimburse the officers and directors for reasonable out-of-pocket expenses incurred by them in connection with certain activities on the Company’s behalf such as identifying and investigating possible target businesses and business combinations.

 

Other than as set forth in Item 1.01 of this report and the Registration Statement, none of the directors mentioned above are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions involving the Company required to be disclosed under Item 404(a) of Regulation S-K.

  

Item 5.03 Amendments to the Memorandum and Articles of Association.

 

On June 24, 2026, the Company adopted, by special resolution, its Amended and Restated Memorandum and Articles of Association, effective upon the listing of the Company’s public units on the Designated Stock Exchange (as defined therein). The Amended and Restated Memorandum and Articles of Association is filed as Exhibit 3.1 to this report and is incorporated by reference herein.

 

Item 8.01 Other Events.

 

A total of $115,000,000, from the proceeds of the IPO and the sale of the Private Units (net of transaction expenses and working capital) were placed in the Company’s trust account. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes and dissolution expenses, the proceeds from the IPO and the sale of the Private Units held in the trust account will not be released until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with an initial business combination or to redeem 100% of the Company’s public shares if the Company does not complete the Company’s initial business combination within 12 months from the consummation of the IPO, or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, and (iii) the redemption of all the Company’s public shares if the Company is unable to complete its initial business combination within 12 months from the consummation of the IPO, subject to applicable law.

 

On June 24, 2026, the Company issued a press release, a copy of which is filed as Exhibit 99.1 to this report, announcing the pricing of the IPO.

 

On June 26, 2026, the Company issued a press release, a copy of which is filed as Exhibit 99.2 to this report, announcing the closing of the IPO.

 

2

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description of Exhibits
1.1   Underwriting Agreement, dated June 24, 2026, by and between the Company and the Representative.
     
3.1   Amended and Restated Memorandum and Articles of Association, dated June 24, 2026.
     
4.1   Warrant Agreement, dated June 24, 2026, between the Company and VStock, as warrant agent.
     
4.2   Rights Agreement, dated June 24, 2026, between the Company and VStock, as rights agent.
     
10.1   Securities Transfer Agreement, dated June 24, 2026, among the Company and certain directors of the Company.
     
10.2   Private Unit Subscription Agreement, dated June 24, 2026, between the Company and the Sponsor.
     
10.3   Investment Management Trust Agreement, dated June 24, 2026, between the Company and Equiniti, as trustee.
     
10.4   Registration Rights Agreement, dated June 24, 2026, among the Company, the Sponsor, and certain officers and directors of the Company.
     
10.5   Letter Agreement, dated June 24, 2026, among the Company, the Sponsor, and certain officers and directors of the Company.
     
10.6   Indemnity Agreement, dated June 24, 2026, between the Company and Xiaolin Zheng.
     
10.7   Indemnity Agreement, dated June 24, 2026, between the Company and Ying Xu.
     
10.8   Indemnity Agreement, dated June 24, 2026, between the Company and Joy Yi Hua.
     
10.9   Indemnity Agreement, dated June 24, 2026, between the Company and Xin Yue Jasmine Geffner.
     
10.10   Indemnity Agreement, dated June 24, 2026, between the Company and Yuanmei Ma.
     
99.1   Press Release, dated June 24, 2026.
     
99.2   Press Release, dated June 26, 2026.

 

3

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Alpex Acquisition Corporation
     
  By: /s/ Xiaolin Zheng
  Name:  Xiaolin Zheng
  Title: Chief Executive Officer
     
Date: June 29, 2026    

 

4

 

Exhibit 99.1

 

ALPEX ACQUISITION CORPORATION ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

 

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) — Alpex Acquisition Corporation (NASDAQ: ALPXU) (“Alpex”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under “ALPXU” beginning June 25, 2026. Each unit consists of one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of one Class A ordinary share upon consummation of an initial business combination. Each whole redeemable warrant entitles the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share. Upon separate trading, the Class A ordinary shares, warrants and rights are expected to be listed on Nasdaq under “ALPX,” “ALPXW,” and “ALPXR,” respectively.

 

D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on June 26, 2026, subject to customary closing conditions.

 

A registration statement on Form S-1 (File No. 333- 294978) for these securities was declared effective by the SEC on June 24, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.

 

This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.

 

About Alpex Acquisition Corporation

 

Alpex is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Alpex’s target search will not be limited to a particular industry or geographic region.

 

Forward-Looking Statements

 

This press release contains “forward-looking statements,” including statements regarding Alpex’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Alpex’s control, including those in the Risk Factors section of Alpex’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Alpex disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Alpex’s expectations, except as required by law.

 

Contact

 

Alpex Acquisition Corporation
Ying Xu
Chief Financial Officer

 

executive@alpexacquisitioncorp.com

 

 

Exhibit 99.2

 

Alpex Acquisition Corporation Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Over-allotment Option

 

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) — Alpex Acquisition Corporation (NASDAQ: ALPXU) (the “Company”), a Cayman Islands exempted company, announced today the closing of its initial public offering of 11,500,000 units at $10.00 per unit, which includes the full exercise of the underwriters’ option to purchase an additional 1,500,000 units to cover over-allotments. The gross proceeds from the offering were $115,000,000 before deducting underwriting discounts and estimated offering expenses.  The units are listed on the Nasdaq Global Market (“Nasdaq”) and began trading under the ticker symbol “ALPXU” on June 25, 2026. Each unit consists of one Class A ordinary share, one redeemable warrant, and one right to receive one-fourth of one Class A ordinary share upon consummation of an initial business combination. Each redeemable warrant entitles the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares, warrants and rights are expected to be listed on Nasdaq under “ALPX,” “ALPXW,” and “ALPXR,” respectively.

 

Concurrently with the closing of the initial public offering, the Company closed a private placement of 187,500 units at a price of $10.00 per unit, resulting in gross proceeds of $1,875,000. The private placement units are identical to the units sold in the initial public offering, subject to certain limited exceptions as described in the final prospectus.

 

D. Boral Capital LLC acted as sole book-running manager of the offering. The Company was represented by Robinson & Cole LLP as its legal counsel, and D. Boral Capital LLC was represented by Rimon, P.C. as its legal counsel.

 

Of the net proceeds received from the consummation of the initial public offering and simultaneous private placement, $115,000,000.00 ($10.00 per unit sold in the public offering) was placed in trust. An audited balance sheet of the Company as of June 26, 2026, reflecting receipt of the proceeds upon the consummation of the initial public offering and the private placement, will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”).

 

A final prospectus relating to and describing the final terms of the offering has been filed with the SEC. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com. Copies of the final prospectus can also be accessed through the SEC’s website at www.sec.gov.

 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

About Alpex Acquisition Corporation

 

Alpex Acquisition Corporation is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region.

 

Forward-Looking Statements

 

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement, preliminary prospectus and final prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.

 

Contact:

 

Alpex Acquisition Corporation
Ying Xu
Chief Financial Officer
executive@alpexacquisitioncorp.com

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

16 documents

Press Releases

Agreements & Contracts

Other Documents